Items where Author is "Fuchs, Michael"

Article

Borchmann, Peter and Plutschow, Annette and Kobe, Carsten and Greil, Richard and Meissner, Julia and Topp, Max S. and Ostermann, Helmut and Dierlamm, Judith and Mohm, Johannes and Thiemer, Julia and Sokler, Martin and Kerkhoff, Andrea and Ahlborn, Miriam and Halbsguth, Teresa and Martin, Sonja and Keller, Ulrich and Balabanov, Stefan and Pabst, Thomas and Vogelhuber, Martin and Huttmann, Andreas and Wilhelm, Martin and Zijlstra, Josee M. and Moccia, Alden and Kuhnert, Georg and Brockelmann, Paul J. and von Tresckow, Bastian and Fuchs, Michael and Klimm, Beate and Rosenwald, Andreas and Eich, Hans and Baues, Christian and Marnitz, Simone and Hallek, Michael and Diehl, Volker and Dietlein, Markus and Engert, Andreas (2021) PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial. LANCET ONCOLOGY, 22 (2). pp. 223-234. ISSN 1470-2045, 1474-5488

Boell, Boris and Pluetschow, Annette and Buerkle, Carolin and Atta, Johannes and Pfreundschuh, Michael and Feuring-Buske, Michaela and Vogelhuber, Martin and Soekler, Martin and Eichenauer, Dennis A. and Thielen, Indra and von Tresckow, Bastian and Fuchs, Michael and Engert, Andreas and Borchmann, Peter (2019) Doxorubicin, vinblastine, dacarbazine and lenalidomide for older Hodgkin lymphoma patients: final results of a German Hodgkin Study Group (GHSG) phase-I trial. BRITISH JOURNAL OF HAEMATOLOGY, 185 (1). pp. 42-52. ISSN 0007-1048, 1365-2141

Fuchs, Michael and Goergen, Helen and Kobe, Carsten and Kuhnert, Georg and Lohri, Andreas and Greil, Richard and Sasse, Stephanie and Topp, Max S. and Schaefer, Erhardt and Hertenstein, Bernd and Soekler, Martin and Vogelhuber, Martin and Zijlstra, Josee M. and Keller, Ulrich Bernd and Krause, Stefan W. and Wilhelm, Martin and Maschmeyer, Georg and Thiemer, Julia and Duehrsen, Ulrich and Meissner, Julia and Viardot, Andreas and Eich, Hans and Baues, Christian and Diehl, Volker and Rosenwald, Andreas and von Tresckow, Bastian and Dietlein, Markus and Borchmann, Peter and Engert, Andreas (2019) Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group. JOURNAL OF CLINICAL ONCOLOGY, 37 (31). 2835-+. ISSN 0732-183X, 1527-7755

Behringer, Karolin and Goergen, Helen and Hitz, Felicitas and Zijlstra, Josee M. and Greil, Richard and Markova, Jana and Sasse, Stephanie and Fuchs, Michael and Topp, Max S. and Soekler, Martin and Mathas, Stephan and Meissner, Julia and Wilhelm, Martin and Koch, Peter and Lindemann, Hans-Walter and Schalk, Enrico and Semrau, Robert and Kriz, Jan and Vieler, Tom and Bentz, Martin and Lange, Elisabeth and Mahlberg, Rolf and Hassler, Andre and Vogelhuber, Martin and Hahn, Dennis and Mezger, Joerg and Krause, Stefan W. and Skoetz, Nicole and Boell, Boris and von Tresckow, Bastian and Diehl, Volker and Hallek, Michael and Borchmann, Peter and Stein, Harald and Eich, Hans and Engert, Andreas (2015) Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial. LANCET, 385 (9976). pp. 1418-1427. ISSN 0140-6736, 1474-547X

Engert, Andreas and Haverkamp, Heinz and Kobe, Carsten and Markova, Jana and Renner, Christoph and Ho, Antony and Zijlstra, Josee and Kral, Zdenek and Fuchs, Michael and Hallek, Michael and Kanz, Lothar and Doehner, Hartmut and Doerken, Bernd and Engel, Nicole and Topp, Max and Klutmann, Susanne and Amthauer, Holger and Bockisch, Andreas and Kluge, Regine and Kratochwil, Clemens and Schober, Otmar and Greil, Richard and Andreesen, Reinhard and Kneba, Michael and Pfreundschuh, Michael and Stein, Harald and Eich, Hans Theodor and Mueller, Rolf-Peter and Dietlein, Markus and Borchmann, Peter and Diehl, Volker (2012) Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial. LANCET, 379 (9828). pp. 1791-1799. ISSN 0140-6736

Engert, Andreas and Josting, Andreas and Haverkamp, Heinz and Villalobos, Matthias and Lohri, Andreas and Soekler, Martin and Zijlstra, Josee and Sturm, Isrid and Topp, Max S. and Rank, Andreas and Zenz, Thorsten and Vogelhuber, Martin and Nogova, Lucia and Borchmann, Peter and Fuchs, Michael and Flechtner, Hans-Henning and Diehl, Volker (2010) Epoetin Alfa in Patients With Advanced-Stage Hodgkin's Lymphoma: Results of the Randomized Placebo-Controlled GHSG HD15EPO Trial. JOURNAL OF CLINICAL ONCOLOGY, 28 (13). pp. 2239-2245. ISSN 0732-183X

Conference or Workshop Item

Jacob, Anne Sophie and Fuchs, Michael and Kaul, Helen and Kobe, Carsten and Pabst, Thomas and Greil, Richard and Eichenauer, Dennis and Topp, Max and Just, Marianne and Hertenstein, Bernd and Schaub, Valdete and Vogelhuber, Martin and Zijlstra, Josee M. and Pluetschow, Annette and Baues, Christian and Rosenwald, Andreas and Dietlein, Markus and Borchmann, Peter and Engert, Andreas (2022) PET-Guided Treatment in Patients with Early-Stage Favorable Hodgkin Lymphoma: Follow-up Analysis of the HD16 Trial by the German Hodgkin Study Group. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.

Other

Fuchs, Michael and Jacob, Anne Sophie and Kaul, Helen and Kobe, Carsten and Kuhnert, Georg and Pabst, Thomas and Greil, Richard and Broeckelmann, Paul J. and Topp, Max S. and Just, Marianne and Hertenstein, Bernd and Soekler, Martin and Vogelhuber, Martin and Zijlstra, Josee M. and Keller, Ulrich Bernd and Krause, Stefan W. and Duehrsen, Ulrich and Meissner, Julia and Viardot, Andreas and Eich, Hans-Theodor and Baues, Christian and Diehl, Volker and Rosenwald, Andreas and Buehnen, Ina and von Tresckow, Bastian and Dietlein, Markus and Borchmann, Peter and Engert, Andreas and Eichenauer, Dennis A. (2023) Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma. SPRINGERNATURE, LONDON.